LRRK2 and Parkinson disease: Higher 2-aminobutyrate (2-AB) were observed in PD PRKN. 2-AB was found at zero levels for the patient groups of PD LRRK2 positive and the double mutation carrier individuals’ samples (Supplementary Table 1).